MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

October 13, 2017

Guadalajara, Mexico, October 13, 2017People with drug-resistant tuberculosis (DR-TB) are still not receiving two newer tuberculosis (TB) drugs, bedaquiline and delamanid, which have shown improved cure rates for the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the 48th Union World Conference on Lung Health in Guadalajara, Mexico, where the global TB community is meeting.

September 11, 2017

Recent attacks on Zemio, in southeast Central African Republic, have closed the hospital and forced the city’s population, including MSF staff members, to flee. Doctors Without Borders/Médecins Sans Frontières (MSF) medical coordinator Wil van Roekel describes the ramifications of the violence for patients, including on some 1,600 HIV patients who need daily medication to survive.

August 30, 2017

Yury*, 38, is celebrating a moment he thought would never arrive: he has been cured of extensively drug-resistant tuberculosis (XDR-TB). This moment is also a milestone for Doctors Without Borders/Médecins Sans Frontières (MSF): Yury is the first patient to complete MSF’s tuberculosis treatment program in Belarus, run in close cooperation with the Ministry of Health.

August 15, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) nurse and researcher, Chenai Mathabire, received the International Aids Society 2017 TB/HIV Research Prize for research on a rapid tuberculosis (TB) test. View External Media.

August 01, 2017

Following the International AIDS conference, UNAIDS released a report that indicates more than half of the 36.7 million people with HIV have access to treatment for the first time. Despite this encouraging statistic, both HIV and AIDS death rates are increasing in Central Asia and Eastern Europe. NPR spoke with Doctors Without Borders/Médecins Sans Frontières (MSF) HIV and TB policy adviser, Sharonann Lynch, about the most recent HIV/AIDS trends. 

July 11, 2017

This year's G20 declaration lays out the importance of promoting research and development to combat tuberculosis' (TB) "threat to public health and economic growth." Prior to the summit, Doctors Without Borders/Médecins Sans Frontières (MSF) urged G20 leaders to take action on drug-resistant infections, including TB. View External Media.

July 06, 2017

Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

Pages

October 13, 2017

Guadalajara, Mexico, October 13, 2017People with drug-resistant tuberculosis (DR-TB) are still not receiving two newer tuberculosis (TB) drugs, bedaquiline and delamanid, which have shown improved cure rates for the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the 48th Union World Conference on Lung Health in Guadalajara, Mexico, where the global TB community is meeting.

September 11, 2017

Recent attacks on Zemio, in southeast Central African Republic, have closed the hospital and forced the city’s population, including MSF staff members, to flee. Doctors Without Borders/Médecins Sans Frontières (MSF) medical coordinator Wil van Roekel describes the ramifications of the violence for patients, including on some 1,600 HIV patients who need daily medication to survive.

August 30, 2017

Yury*, 38, is celebrating a moment he thought would never arrive: he has been cured of extensively drug-resistant tuberculosis (XDR-TB). This moment is also a milestone for Doctors Without Borders/Médecins Sans Frontières (MSF): Yury is the first patient to complete MSF’s tuberculosis treatment program in Belarus, run in close cooperation with the Ministry of Health.

August 15, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) nurse and researcher, Chenai Mathabire, received the International Aids Society 2017 TB/HIV Research Prize for research on a rapid tuberculosis (TB) test. View External Media.

August 01, 2017

Following the International AIDS conference, UNAIDS released a report that indicates more than half of the 36.7 million people with HIV have access to treatment for the first time. Despite this encouraging statistic, both HIV and AIDS death rates are increasing in Central Asia and Eastern Europe. NPR spoke with Doctors Without Borders/Médecins Sans Frontières (MSF) HIV and TB policy adviser, Sharonann Lynch, about the most recent HIV/AIDS trends. 

July 11, 2017

This year's G20 declaration lays out the importance of promoting research and development to combat tuberculosis' (TB) "threat to public health and economic growth." Prior to the summit, Doctors Without Borders/Médecins Sans Frontières (MSF) urged G20 leaders to take action on drug-resistant infections, including TB. View External Media.

July 06, 2017

Ahead of the G20 summit in Hamburg, where global health is on the agenda for the first time, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) called on G20 leaders to follow through on the declaration made by their health ministers in late May.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

May 25, 2017

Ahead of the G7 summit that’s starting tomorrow in Italy, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is urging participating countries to address high medicine prices and drug-resistant infections, which affect people everywhere. Today, across the G7, countries are struggling to pay for new medicines to treat life-threatening illnesses like hepatitis C.

Pages